【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Helicobacter Pylori Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Helicobacter Pylori Infections 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Helicobacter Pylori Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Helicobacter Pylori Infections 33
Jun 08, 2015: RedHill Biopharma Completes Treatment of Last Patient with RHB-105 in Phase III Study 33
Jun 03, 2015: RedHill Biopharma Provides Update on Development Pipeline and Expected Timing for RHB-105 Phase III Top-Line Results 33
May 07, 2015: RedHill Biopharma to Host Investor Webcast Forum Following Completion of RHB-105 Dosing in Phase III Study 35
Apr 27, 2015: RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
RedHill Biopharma Ltd. 37
Clinical Trial Overview of RedHill Biopharma Ltd. 37
AstraZeneca Plc 38
Clinical Trial Overview of AstraZeneca Plc 38
MerLion Pharmaceuticals Pte Ltd 39
Clinical Trial Overview of MerLion Pharmaceuticals Pte Ltd 39
Aspen Pharmacare Holdings Ltd 40
Clinical Trial Overview of Aspen Pharmacare Holdings Ltd 40
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Otsuka Holdings Co., Ltd. 42
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
Forest Laboratories, Inc. 44
Clinical Trial Overview of Forest Laboratories, Inc. 44
Chemo Espana, S.A. 45
Clinical Trial Overview of Chemo Espana, S.A. 45
Bluefish Pharmaceuticals AB 46
Clinical Trial Overview of Bluefish Pharmaceuticals AB 46
Clinical Trial Overview of Top Institutes / Government 47
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
Tehran University of Medical Sciences 48
Clinical Trial Overview of Tehran University of Medical Sciences 48
Mazandaran University of Medical Sciences 49
Clinical Trial Overview of Mazandaran University of Medical Sciences 49
Keio University 50
Clinical Trial Overview of Keio University 50
Shanghai Jiao Tong University School of Medicine 51
Clinical Trial Overview of Shanghai Jiao Tong University School of Medicine 51
Buddhist Tzu Chi General Hospital 52
Clinical Trial Overview of Buddhist Tzu Chi General Hospital 52
Guilan University of Medical Sciences 53
Clinical Trial Overview of Guilan University of Medical Sciences 53
Kaohsiung Veterans General Hospital. 54
Clinical Trial Overview of Kaohsiung Veterans General Hospital. 54
The University of Tokyo Hospital 55
Clinical Trial Overview of The University of Tokyo Hospital 55
National Cancer Center 56
Clinical Trial Overview of National Cancer Center 56
Five Key Clinical Profiles 57
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77
【レポート販売概要】
■ タイトル：ヘリコバクター・ピロリ感染症：世界の治験レビュー（2015年上半期版）■ 英文：Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015
■ 発行日：2015年6月16日
■ 調査会社：GlobalData
■ 商品コード：GDHC2732CTIDB
■ 調査対象地域：グローバル
- 公衆安全およびセキュリティソリューションの世界市場予測：クリティカル通信ネットワーク、バイオメトリクス、認証システム、監視システム、緊急事態・災害管理、サイバーセキュリティThe public safety and security market size is expected to grow from USD 247.53 Billion in 2016 to USD 456.56 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 13.0% during the forecast period. The major growth drivers of the market include rise in criminal activities, natural disaster & cross border terrorism, need for stringent government policies & regulations for public safety, and in …
- 2014年戦略提言：フランスの臨床化学・免疫診断市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. “2014 Strategies for the French Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the French clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the French market …
- エンタープライズアプリケーションSIの世界市場2015-2019About Global Enterprise Application System Integration Businesses worldwide depend on technology and integration solutions to sustain smooth business operations and drive revenue growth. Innovative IT applications and integrated solutions have enriched businesses functions. Enterprise application system integration has become a key enabler for streamlining business functions. Going forward, this t …
- 世界における特殊合成繊維及びガラス繊維市場動向及び予測（～2018）The specialty synthetic fibers and glass fiber market had a consumption of 4,652,100.2 MT in 2012, with the highest share held by Glass fiber. The global market is projected to grow at a CAGR of 5.2% from 2013 to 2018. The highest revenue is forecasted to be for glass fiber, owing to the low pricing as compared to other specialty synthetic fibers, growing application markets, availability of raw m …
- 生物活性創傷ケアの世界市場分析：製品別（湿式創傷ケア、抗菌創傷ケア、アクティブ創傷ケア）、セグメント予測The global bioactive wound care market is expected to reach USD 11.9 billion by 2024, according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions …
- 抗体生産の世界市場：抗体生産装置（バイオリアクター、遠心機、限外ろ過装置）、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies such as recombinant technology and antibody phage-display technology. Due t …
- カバーガラスの世界市場2016-2020About Cover Glass Cover glass is thin, lightweight glass material often used in the displays of portable electronic devices such as all-in-one (AIO) PCs, smartphones, tablets, and portable navigation devices. Cover glass manufacturers focus on incorporating features like durability, scratch resistance, and damage resistance to gain a competitive advantage in the market. Display device manufacturer …
- 企業アプリケーション統合の世界市場2016-2020About Enterprise Application Integration (EAI) EAI is an integration framework, a middleware, which combines different technologies and services to establish smooth integration of applications and information systems such as ERP, SCM, CRM, HRM, and BI applications throughout the enterprise. It enables real-time data sharing and automation of business processes. EAI integrates multiple disparate bu …
- Exxon Mobil Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Exxon Mobil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Exxon Mobil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- 世界のディジタルオシロスコープ市場動向（2012-2016）TechNavio's analysts forecast the Global Digital Oscilloscope market to grow at a CAGR of 19.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for self-monitored and signal storage facilities. The Global Digital Oscilloscope market has also been witnessing the increasing preference for high-end digital oscilloscopes. However, th …
- 冷凍ピザの世界市場2015-2019About Frozen Pizza A frozen pizza is a ready-made pizza that consumers can store in their refrigerators and consume as and when required. The shelf life of a frozen pizza is approximately 4-6 months, if stored in a freezer. Frozen pizzas when heated are as soft and tasty as freshly baked pizza. TechNavio's analysts forecast the Global Frozen Pizza market to grow at a CAGR of 2.54 percent in terms …
- 無人航空機（UAV）の世界市場予測：業種別、クラス別、システム別、産業別“The UAV market is projected to grow at a CAGR of 15.5% during the forecast period.”The UAV market is projected to grow from USD 19.3 billion in 2019 to USD 45.8 billion by 2025, at a CAGR of 15.5% during the forecast period. The increasing use of unmanned aerial vehicles in commercial and military applications is one of the most significant factors expected to drive the growth of the UAV market. …
- 鉄道管理システムの世界市場展望2017-20276According to Stratistics MRC, the Global Railway Management System market is accounted for $28.50 billion in 2017 and is expected to reach $83.88 billion by 2026 growing at a CAGR of 12.7%. Factors such as high demographic growth, hyper-urbanization and technological advancements are driving the market growth. However, high initial cost of deployment is hampering the growth of market. The railway …
- 世界の 産業オートメーション・コントロール（Automation Control）市場動向（2014-2018）TechNavio's analysts forecast the Global Industrial Automation Control market to grow at a CAGR of 6.87 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for automation control systems from the Oil and Gas industry. The Global Industrial Automation Control market has also been witnessing the increased availability of wireless sens …
- 鎮静作用(Sedation)の治療薬パイプライン動向（2015年上半期版）Sedation - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sedation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administr …
